Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-23

Clinical Trial Update: Pembrolizumab and Palliative Radiotherapy in Lung [Phase 1]

View source ↗

Summary

Phase 1 study evaluating pembrolizumab with palliative radiotherapy in thoracic tumors (lung). The trial has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Royal Marsden NHS Foundation Trust | Conditions: Thoracic Tumours | Phase 1 | Status: COMPLETED | Results posted: 2026-04-23